Doubleblind, randomized, placebo controlled clinical trial to proof the efficacy of a comfrey extract in subjects with painfull gonarthrosis
- Conditions
- Painfull gonarthrosis
- Registration Number
- EUCTR2005-003144-65-DE
- Lead Sponsor
- Merck Selbstmedikation GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 220
Inclusion Criteria
- Age 18 years and older
- Intensity of pain at least 40 mm of a 100 mm VAS (Cisual analog scale)
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- Intake of steroids during the last 4 weeks before the start of the trial
- Intake of analgetica (besides Paracetamol up to 2 g = 4x 500 g daily)
- Intake of systemic and/or local antiphlogistica/antirheumatica before the start of the trial
- Severe systemic or organic diseases
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Proof of a significant therapeutic effect of Kytta-Salbe f compared to placebo.;Secondary Objective: ;Primary end point(s): Investigation of pain (in rest and in motion) by using VAS
- Secondary Outcome Measures
Name Time Method